President Obama signed the Drug Quality and Safety Act into law on November 27, 2013. This sent the United States pharmaceutical industry down a specific path to improve the lives of patients. The law was designed to combat counterfeiting, theft, and contamination in the drug supply chain through the use of serialization, aggregation, and …